Showing results (151-160 of 4,510) with videos related to

Sort By:
Pageof 451
Future Oncology (London, England)|March 1, 2019
INSIGHT MM: a large, global, prospective, non-interventional, real-world study of patients with multiple myelomaCaitlin Costello, Faith E Davies, Gordon Cook, et al.
Future Oncology (London, England)|November 23, 2018
Trabectedin for reversing platinum resistance and resensitization to platinum in patients with recurrent ovarian cancerAntonio Casado, Hector R Callata, Aranzazu Manzano, et al.
Future Oncology (London, England)|November 17, 2018
A review discussing the use of polyethylene glycol microspheres in the treatment of hepatocellular carcinomaGiammaria Fiorentini, Donatella Sarti, Riccardo Carandina, et al.
Future Oncology (London, England)|November 20, 2018
A comparative evaluation of gemtuzumab ozogamicin + daunorubicin-cytarabine and other treatments for newly diagnosed acute myeloid leukemiaAjibade O Ashaye, Zarmina Khankhel, Yingxin Xu, et al.
Future Oncology (London, England)|November 21, 2018
Gene expression profiling in melanoma: past results and future potentialRebecca W Knackstedt, Thomas Knackstedt, Brian Gastman
Future Oncology (London, England)|November 24, 2018
Long noncoding RNAs as biotargets in cisplatin-based drug resistanceNadiah Abu, Kha Wai Hon, Shivapriya Jeyaraman, et al.
Future Oncology (London, England)|February 16, 2019
CanStem111P trial: a Phase III study of napabucasin plus nab-paclitaxel with gemcitabineMohamad Bassam Sonbol, Daniel H Ahn, David Goldstein, et al.
Future Oncology (London, England)|March 8, 2019
Curcumin exerts cytotoxicity dependent on reactive oxygen species accumulation in non-small-cell lung cancer cellsCuijuan Wang, Xingguo Song, Ming Shang, et al.
Future Oncology (London, England)|March 9, 2019
Enzalutamide, an oral androgen receptor inhibitor for treatment of castration-resistant prostate cancerCora N Sternberg
Future Oncology (London, England)|February 5, 2021
Relationship between antidepressive agents and incidence risk of breast cancer: systematic review and meta-analysisRui Li, Xiuxia Li, Peijing Yan, et al.
Pageof 451